Fisher KD - Search Results

1

Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.

Scott EM, Jacobus EJ, Lyons B, Frost S, Freedman JD, Dyer A, Khalique H, Taverner WK, Carr A, Champion BR, Fisher KD, Seymour LW, Duffy MR. Scott EM, et al. Among authors: fisher kd. J Immunother Cancer. 2019 Nov 21;7(1):320. doi: 10.1186/s40425-019-0807-6. J Immunother Cancer. 2019. PMID: 31753017 Free PMC article.

2

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

Fisher KD, Stallwood Y, Green NK, Ulbrich K, Mautner V, Seymour LW. Fisher KD, et al. Gene Ther. 2001 Mar;8(5):341-8. doi: 10.1038/sj.gt.3301389. Gene Ther. 2001. PMID: 11313809

3

Adenovirus retargeting and systemic delivery.

Seymour LW, Fisher KD, Green NK, Hale SJ, Lyons M, Mautner V, Nicum S, Onion D, Oupicky D, Stevenson M, Ulbrich K. Seymour LW, et al. Among authors: fisher kd. Ernst Schering Res Found Workshop. 2003;(43):107-14. doi: 10.1007/978-3-662-05352-2_8. Ernst Schering Res Found Workshop. 2003. PMID: 12894454 Review. No abstract available.

4

Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus.

Green NK, Herbert CW, Hale SJ, Hale AB, Mautner V, Harkins R, Hermiston T, Ulbrich K, Fisher KD, Seymour LW. Green NK, et al. Among authors: fisher kd. Gene Ther. 2004 Aug;11(16):1256-63. doi: 10.1038/sj.gt.3302295. Gene Ther. 2004. PMID: 15215884

5

Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells.

Stevenson M, Boos E, Herbert C, Hale A, Green N, Lyons M, Chandler L, Ulbrich K, van Rooijen N, Mautner V, Fisher K, Seymour L. Stevenson M, et al. Gene Ther. 2006 Feb;13(4):356-68. doi: 10.1038/sj.gt.3302655. Gene Ther. 2006. PMID: 16355117

6

Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA.

Carlisle RC, Briggs SS, Hale AB, Green NK, Fisher KD, Etrych T, Ulbrich K, Mautner V, Seymour LW. Carlisle RC, et al. Among authors: fisher kd. Gene Ther. 2006 Nov;13(22):1579-86. doi: 10.1038/sj.gt.3302814. Epub 2006 Jun 29. Gene Ther. 2006. PMID: 16810196

7

Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins.

Stevenson M, Hale AB, Hale SJ, Green NK, Black G, Fisher KD, Ulbrich K, Fabra A, Seymour LW. Stevenson M, et al. Among authors: fisher kd. Cancer Gene Ther. 2007 Apr;14(4):335-45. doi: 10.1038/sj.cgt.7701022. Epub 2007 Jan 19. Cancer Gene Ther. 2007. PMID: 17235355

8

Directed evolution generates a novel oncolytic virus for the treatment of colon cancer.

Kuhn I, Harden P, Bauzon M, Chartier C, Nye J, Thorne S, Reid T, Ni S, Lieber A, Fisher K, Seymour L, Rubanyi GM, Harkins RN, Hermiston TW. Kuhn I, et al. PLoS One. 2008 Jun 18;3(6):e2409. doi: 10.1371/journal.pone.0002409. PLoS One. 2008. PMID: 18560559 Free PMC article.

9

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.

Bazan-Peregrino M, Carlisle RC, Hernandez-Alcoceba R, Iggo R, Homicsko K, Fisher KD, Halldén G, Mautner V, Shen Y, Seymour LW. Bazan-Peregrino M, et al. Among authors: fisher kd. Hum Gene Ther. 2008 Sep;19(9):873-86. doi: 10.1089/hum.2008.047. Hum Gene Ther. 2008. PMID: 18710328

10

Adenovirus: teaching an old dog new tricks.

Seymour LW, Fisher KD. Seymour LW, et al. Among authors: fisher kd. Hum Gene Ther. 2011 Sep;22(9):1041-2. doi: 10.1089/hum.2011.2517. Hum Gene Ther. 2011. PMID: 21932993 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page